Docoh
Loading...

JAGX Jaguar Health

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. Its Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy and the only oral plant-based prescription medicine approved under FDA Botanical Guidance.

JAGX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

13 Aug 21
25 Oct 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 31.91M 31.91M 31.91M 31.91M 31.91M 31.91M
Cash burn (monthly) 112.67K (positive/no burn) 4.69M 3.56M 3.3M 1.97M
Cash used (since last report) 433.22K n/a 18.05M 13.69M 12.7M 7.56M
Cash remaining 31.48M n/a 13.86M 18.22M 19.21M 24.35M
Runway (months of cash) 279.4 n/a 3.0 5.1 5.8 12.4

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
4 Jun 21 Bochnowski James J Common Stock Sell Dispose S No No 1.74 152 264.48 954,390
3 Jun 21 Bochnowski James J Common Stock Sell Dispose S No No 1.75 292 511 954,542
18 May 21 Bochnowski James J RSU Common Stock Grant Acquire A No No 0 39,400 0 39,400
18 May 21 Bochnowski James J Stock option Common Stock Grant Acquire A No No 1.24 78,750 97.65K 78,750
18 May 21 Divis Gregory J RSU Common Stock Grant Acquire A No No 0 36,400 0 36,400
18 May 21 Divis Gregory J Stock option Common Stock Grant Acquire A No No 1.24 72,750 90.21K 72,750
18 May 21 Micek John RSU Common Stock Grant Acquire A No No 0 36,400 0 36,400
18 May 21 Micek John Stock option Common Stock Grant Acquire A No No 1.24 72,750 90.21K 72,750
18 May 21 Siegel Jonathan B. RSU Common Stock Grant Acquire A No No 0 36,400 0 36,400
18 May 21 Siegel Jonathan B. Stock option Common Stock Grant Acquire A No No 1.24 72,750 90.21K 72,750

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

24.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 39 46 -15.2%
Opened positions 8 33 -75.8%
Closed positions 15 6 +150.0%
Increased positions 9 9
Reduced positions 4 1 +300.0%
13F shares
Current Prev Q Change
Total value 55.06M 36.94M +49.0%
Total shares 33.82M 21.34M +58.5%
Total puts 234.6K 364.7K -35.7%
Total calls 313.3K 394.6K -20.6%
Total put/call ratio 0.7 0.9 -19.0%
Largest owners
Shares Value Change
Oasis Capital 6.87M $22.27M 0.0%
Renaissance Technologies 5.58M $8.82M +6865.2%
Vanguard 5.43M $8.58M +188.7%
Iliad Research & Trading 4.75M $930K 0.0%
Millennium Management 2.79M $4.41M +193.8%
BLK Blackrock 2.33M $3.69M +25.4%
Baillie Gifford & Co 2.03M $0 0.0%
PFG Principal Financial Group Inc - Registered Shares 1.19M $1.88M NEW
Geode Capital Management 1.09M $1.72M +25.3%
Group One Trading 499.99K $790K +781.7%
Largest transactions
Shares Bought/sold Change
Renaissance Technologies 5.58M +5.5M +6865.2%
Vanguard 5.43M +3.55M +188.7%
Millennium Management 2.79M +1.84M +193.8%
PFG Principal Financial Group Inc - Registered Shares 1.19M +1.19M NEW
BLK Blackrock 2.33M +472.36K +25.4%
Group One Trading 499.99K +443.28K +781.7%
STT State Street 395.52K +395.52K NEW
HRT Financial 0 -257.01K EXIT
Geode Capital Management 1.09M +219.49K +25.3%
Susquehanna International 179.68K -164.71K -47.8%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: adult, Agency, aim, BOD, CDD, CTD, dispense, European, intestinal, Italian, NaN, noncancellable, occupancy, pathway, pediatric, political, portfolio, provision, real, Russia, sponsor, subscription, undiscounted, wholly
Removed: carried, compare, competitive, considerable, consumer, fulltime, Henry, high, IBS, institution, judgement, lead, partially, proportionate, Schein, terminal, test